|
| 36912538 | Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. | N Engl J Med | 2023 |
| 37945903 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Nat Genet | 2023 |
| 37292833 | Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry. | medRxiv | 2023 |
| 37311464 | Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry. | Am J Hum Genet | 2023 |
| 37296430 | Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP). | BMC Health Serv Res | 2023 |
| 34599350 | A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections. | World J Urol | 2022 |
| 36201131 | Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial. | Pharmacoeconomics | 2022 |
| 35152271 | Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. | Prostate Cancer Prostatic Dis | 2022 |
| 33473200 | Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 33623038 | Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. | Nat Commun | 2021 |
| 33580906 | Identification of a serum biomarker signature associated with metastatic prostate cancer. | Proteomics Clin Appl | 2021 |
| 34469575 | Correction to 'Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation'. | Nucleic Acids Res | 2021 |
| 33436325 | Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study. | Eur Urol Oncol | 2021 |
| 33398198 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 33420416 | Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. | Prostate Cancer Prostatic Dis | 2021 |
| 32450824 | Independence of HIF1a and androgen signaling pathways in prostate cancer. | BMC Cancer | 2020 |
| 34337468 | Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification. | Eur Urol Open Sci | 2020 |
| 33158149 | The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor. | Cancers (Basel) | 2020 |
| 32773013 | Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT. | Health Technol Assess | 2020 |
| 32624282 | Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330]. | Eur Urol | 2020 |
| 32907896 | Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial. | BMJ Open | 2020 |
| 32514134 | The effect of sample size on polygenic hazard models for prostate cancer. | Eur J Hum Genet | 2020 |
| 30622367 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. | Nat Genet | 2019 |
| 35047778 | Precision prostatectomy: reconciling functional and oncological outcomes. | BMJ Surg Interv Health Technol | 2019 |
| 30237440 | A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer. | Oncogene | 2019 |
| 31548585 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers. | Nat Commun | 2019 |
| 30777372 | Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel. | Eur Urol | 2019 |
| 30921005 | Effect of green tea and lycopene on the insulin-like growth factor system: the ProDiet randomized controlled trial. | Eur J Cancer Prev | 2019 |
| 30873591 | The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies. | Int J Cancer | 2019 |
| 30683880 | Shared heritability and functional enrichment across six solid cancers. | Nat Commun | 2019 |
| 30425058 | A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk. | Cancer Res | 2019 |
| 30597039 | Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. | Int J Epidemiol | 2019 |
| 28753852 | DESNT: A Poor Prognosis Category of Human Prostate Cancer. | Eur Urol Focus | 2018 |
| 29892050 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. | Nat Commun | 2018 |
| 29892016 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. | Nat Genet | 2018 |
| 29878078 | AA9int: SNP interaction pattern search using non-hierarchical additive model set. | Bioinformatics | 2018 |
| 30397198 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry. | Nat Commun | 2018 |
| 30309839 | ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer. | Cancer Prev Res (Phila) | 2018 |
| 29729848 | Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer. | EBioMedicine | 2018 |
| 29353635 | Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV). | Eur J Oncol Nurs | 2018 |
| 29662167 | Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. | Nat Genet | 2018 |
| 29438364 | Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium. | Br J Cancer | 2018 |
| 29438362 | Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. | Br J Cancer | 2018 |
| 29437778 | Identification of potential therapeutic targets in prostate cancer through a cross-species approach. | EMBO Mol Med | 2018 |
| 29509864 | Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. | JAMA | 2018 |
| 29453511 | Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer. | Cancer Causes Control | 2018 |
| 29366640 | Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model: An Individual Patient Data Meta-Analysis. | J Urol | 2018 |
| 29288137 | A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial. | J Clin Epidemiol | 2018 |
| 29278842 | Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study. | Cancer Epidemiol | 2018 |
| 29321194 | Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. | BMJ | 2018 |